DEF6 and endometrioid adenocarcinoma: Among six ovarian carcinoma cells examined, the expression of DEF6 in TOV-112D (endometrioid carcinoma) and OVCAR3 (serous carcinoma) cells were found to be relatively high when compared to other ovarian cells (Fig. 2).